Veterinary medicines European public assessment report (EPAR): Porcilis ColiClos, vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Porcilis ColiClos, vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Cirbloc M Hyo, mycoplasma hyopneumoniae, strain 2940, inactivated,porcine circovirus 2, ORF2 capsid protein, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Cirbloc M Hyo, mycoplasma hyopneumoniae, strain 2940, inactivated,porcine circovirus 2, ORF2 capsid protein, Status: Authorised

EMA risk management information day 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 November 2024, 13:30 (CET) to 21 November 2024, 17:30 (CET)

EMA risk management information day 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 November 2024, 13:30 (CET) to 21 November 2024, 17:30 (CET)

Veterinary medicines European public assessment report (EPAR): Nobivac DP Plus, Canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobivac DP Plus, Canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Hiprabovis IBR Marker Live, live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Hiprabovis IBR Marker Live, live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.